IQVIA Holdings Inc. Share Price

IQVIA Holdings Inc. Share Price

NYSE: IQV | Large Cap
$267.19
-$7.68 (-2.79%) Last updated on 31 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

IQVIA Holdings Inc. Stock Performance

Open
$271.01
Prev. Close
$274.87
Circuit Range
N/A
Day Range
$263.42 - $272.69
Year Range
$154.51 - $284.28
Volume
54,219
Average Traded
$266.29

IQVIA Holdings Inc. Share Price Today

As of 31 October 2026, IQVIA Holdings Inc.'s share price is $267.19. The stock opened at $271.01, compared to its previous close of $274.87. During today's trading session, IQVIA Holdings Inc.'s share price traded between $263.42 and $272.69, with an average price of $268.06. Over the past 52 weeks, the stock has recorded a high of $284.28 and a low of $154.51. In terms of performance, IQVIA Holdings Inc.'s share price has risen by 68.71% over the last six months and is up 23.41% on a year-on-year basis.

IQVIA Holdings Inc. Share Price Chart

Line chart of the IQVIA Holdings Inc. price trend over the selected period. The price fell overall, ranging from 263.22 to 272.81, ending at 267.19.
$263.42$272.69
L
Show Current Price
H

IQVIA Holdings Inc. Stock Fundamentals & Key Indicators

Market Cap
$45.93B
PE Ratio (TTM)
32.52
Dividend Yield
0.00%
EPS (TTM)
$8.46
Revenue (TTM)
$16.31B
Return On Equity (TTM)
20.93%
Profit Margin
8.34%
Debt to Equity
2.41
Quarterly Earnings Growth YoY
-31.91%

IQVIA Holdings Inc. Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$4364.00$4151.00$4368.00$4428.00
Net Profit$514.00$274.00$256.00$350.00
Net Profit Margin11.78%6.60%5.86%7.90%
Income ChangeN/A-46.69%-6.57%36.72%

IQVIA Holdings Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$14.41$14.98$15.41$16.31
Net Profit$1.09$1.36$1.37$1.36
Net Profit Margin7.56%9.08%8.89%8.34%
Income ChangeN/A24.77%0.74%-0.73%

About IQVIA Holdings Inc.

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

IQVIA Holdings Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$267.50
$267.16
-1.05%
Sep 2026
$261.50
$270.00
+2.98%
Aug 2026
$237.34
$262.18
+11.51%
Jul 2026
$197.96
$235.13
+21.69%
Jun 2026
$182.57
$193.22
+6.04%
May 2026
$161.28
$182.22
+15.05%
Apr 2026
$171.40
$158.38
-7.08%
Mar 2026
$175.17
$170.44
-4.76%
Feb 2026
$227.88
$178.96
-22.19%
Jan 2026
$224.94
$230.01
+1.99%
Dec 2025
$229.19
$225.51
-2.19%
Nov 2025
$212.99
$230.56
+6.49%

IQV Share Price FAQs